In certain embodiments, a system filter has a hollow, perforated, inner structure inside a hollow, perforated, outer structure that define an annular gap that receives granular filtering media retained by an (optional) media liner. An outer filter surrounds the outer structure. An (electric) pump may be located within the inner cavity of the inner structure or external to the system filter. When deployed in an underground vault, vault water flows through the outer filter, the outer structure, the outer portion of the media liner (if present), the filtering media, the inner portion of the media liner (if present), and the inner structure into the inner cavity from where the pump moves the filtered water out of the vault. The outer filter and/or the media liner may have a lipophobic, hydrophilic material that allows water to pass while blocking lipids without having the lipids adhere to the material.

Provided is a granular filtration media comprising a mixture of granular filtration media and less than 5% of nanofibers based on the dry weight, method of making the same and uses of the same for removing contaminants from water, including metals, heavy metals, synthetic or natural organic matters, colloidal or suspended particles to improve the chemical safety and purity of water for the purpose of water purification, specifically, one embodiment of the present invention disclosed is use of the granular filtration media to remove particulate lead from high pH water.

Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.

The present invention relates to a process, methods and materials for generating fertilizers from seawater resources, especially in conjunction with seawater desalination plants. Here, we demonstrate that varying compositions of fertilizers such as nitrogen/potassium, nitrogen/phosphorus/potassium, nitrogen/potassium/sulfur, and nitrogen/phosphorus/potassium/sulfur, potassium/sulfur, potassium along with micro and secondary nutrients can directly be generated as part of the extraction process to meet the requirements of both starter and sustained phases of plant growth.

Systems and methods for concentrating an analyte preparatory to analysis thereof include processing the effluent of an analyte concentrator to produce an eluent for eluting an analyte retained in the same or separate concentrator, and systems implementing the same. The analyte concentrator system connects the effluent outlet of an analyte concentrator column to an eluent generation module such that the substantially analyte-free effluent discharged from the analyte concentrator column passes fluidly into the eluent generation module. Eluent generated from the substantially analyte-free effluent in the eluent generation module is likewise substantially free of the analyte. The systems and methods can minimize and/or (substantially) eliminate background signal during analysis of the concentrated analyte.

Disclosed herein are chemical actuators and ionic motive force transducers. The actuators and transducers are capable of converting an electrical stimulus into an ionic gradient within a reaction volume.

The invention relates to a water tank (1) with water filter cartridge (2), characterized in that the water filter cartridge (2) comprises two water filter cartridge outlets which are arranged concentrically to one another.

A method for purifying Reb M includes preparing a crude mother liquor/Stevia rebaudiana primary extract, passing a solution of this primary extract through a multi-column system including a plurality of columns, in series, packed with a porous adsorbent resin to provide at least one column having adsorbed Reb M and eluting fractions with Reb M content from a final/last column in the series to provide an eluted solution with Reb M content.

A bioprocessing system for protein manufacturing from human blood is provided that is compact, integrated and suited for on-demand production and delivery of therapeutic proteins to patients. The patient's own blood can be used as the source of cell extracts for the production of the therapeutic proteins.

Disclosed is a water treatment apparatus that includes a head including an inlet portion into which water flows, an outlet portion from which water is discharged externally, and a connection portion connected to the inlet portion and the outlet portion, and a water treatment unit connected to the connection portion, including a plurality of water treatment sections, coupled to the head, and configured such that a portion of the water flowing into the inlet portion passes through the plurality of water treatment sections and sequentially, the remainder of the water passes through only a portion of the plurality of water treatment sections and, and the water flows to the outlet portion together.